Biogen Settles Whistleblower Kickback Suit for $900 Million

Biogen has agreed to pay $900 million to resolve a federal whistleblower lawsuit charging that the company bribed doctors with kickbacks to prescribe its multiple sclerosis drugs, resulting in the submission of false claims to Medicare and Medicaid.
Source: Drug Industry Daily